Flow cytometric evaluation of multidrug resistance proteins
- PMID: 19949923
- PMCID: PMC7325859
- DOI: 10.1007/978-1-60761-416-6_7
Flow cytometric evaluation of multidrug resistance proteins
Abstract
There are several ways to detect proteins on cells. One quite frequently used method is flow cytometry. This method needs fluorescently labeled antibodies that can attach selectively to the protein to be investigated for flow cytometric detection. Flow cytometry scans individual cells, virtually without their surrounding liquid, and can scan many cells in a very short time. Because of this advantage of flow cytometry, it was adapted to investigate transport proteins on normal and cancerous human cells and cell lines. These transport proteins play important roles in human metabolism. Absorption in the intestine, excretion at the kidney, protection of the CNS compartment and the fetus from xenobiotics, and other vital functions depend on these transporters. However, several transporters are overexpressed in cancer cells. These overexpressed transporters pump out anticancer drugs from the cells and prevent their curative effects. The detection and quantitation of these types of transporters in cancer cells is important for this reason. Here, we review literature on flow cytometric detection of the three most studied transporters: P-glycoprotein, multidrug resistance-associated proteins, and breast cancer resistance protein.
Figures



Similar articles
-
Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.Anal Biochem. 2013 Jun 1;437(1):77-87. doi: 10.1016/j.ab.2013.02.018. Epub 2013 Mar 5. Anal Biochem. 2013. PMID: 23470221 Free PMC article.
-
(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.Nucl Med Biol. 2013 Oct;40(7):873-8. doi: 10.1016/j.nucmedbio.2013.05.012. Epub 2013 Jul 8. Nucl Med Biol. 2013. PMID: 23845421 Free PMC article.
-
The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.J Neurochem. 2008 Dec;107(5):1358-68. doi: 10.1111/j.1471-4159.2008.05730.x. J Neurochem. 2008. PMID: 19013850
-
Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).Drug Metab Pharmacokinet. 2012;27(1):85-105. doi: 10.2133/dmpk.dmpk-11-rv-098. Epub 2011 Nov 29. Drug Metab Pharmacokinet. 2012. PMID: 22123128 Review.
-
Expression and function of multidrug resistance transporters at the blood-brain barriers.Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):233-46. doi: 10.1517/17425255.1.2.233. Expert Opin Drug Metab Toxicol. 2005. PMID: 16922639 Review.
Cited by
-
PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors.Pharmaceutics. 2021 Dec 17;13(12):2181. doi: 10.3390/pharmaceutics13122181. Pharmaceutics. 2021. PMID: 34959462 Free PMC article.
References
-
- Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3–29 - PubMed
-
- Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234 - PubMed
-
- Aleman C, Annereau JP, Liang XJ et al. (2003) P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res 63:3084–3091 - PubMed
-
- Broxterman HJ, Lankelma J, Pinedo HM et al. (1997) Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia. Leukemia 11:1110–1118 - PubMed
-
- Broxterman HJ, Lankelma J, Pinedo HM (1996) How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein. Eur J Cancer 32A:1024–1033 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources